Image via CrunchBase Stocks currently on my Watchlist for top BioPharma plays in the near future.1. Valeant Pharmaceuticals (NYSE:VRX)
Biotechnology Research Report on Valeant's Potiga
On August 11, 2010, we expect the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee to review the marketing application of Valeant Pharmaceuticals International’s (VRX) Potiga (formerly known as Retigabine), designed for the treatment of partial-onset seizures in epilepsy patients who have become refractory (failing to show response to prior therapy) to anti-epilepsy drugs (AEDs).
